Preclinical study demonstrates that oral ovalbumin prevents epicutaneously induced egg allergy in mice, suggesting mucosal tolerance suppresses allergic immune pathways.
Summary Oral ovalbumin administration prevents epicutaneously‐induced egg allergy by suppressing Tfh and B cells and IgE. This prophylactic oral ovalbumin abolishes antigen‐specific IL‐4 and IL‐13 production in skin‐draining lymph nodes.
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Clinical & Experimental Allergy